Zero-augmented beta-prime model for multilevel semi-continuous data: a Bayesian inference

Abstract Semi-continuous data characterized by an excessive proportion of zeros and right-skewed continuous positive values appear frequently in medical research. One example would be the pharmaceutical expenditure (PE) data for which a substantial proportion of subjects investigated may report zero...

Full description

Bibliographic Details
Main Authors: Naser Kamyari, Ali Reza Soltanian, Hossein Mahjub, Abbas Moghimbeigi, Maryam Seyedtabib
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Medical Research Methodology
Subjects:
Online Access:https://doi.org/10.1186/s12874-022-01736-0
_version_ 1811233759006031872
author Naser Kamyari
Ali Reza Soltanian
Hossein Mahjub
Abbas Moghimbeigi
Maryam Seyedtabib
author_facet Naser Kamyari
Ali Reza Soltanian
Hossein Mahjub
Abbas Moghimbeigi
Maryam Seyedtabib
author_sort Naser Kamyari
collection DOAJ
description Abstract Semi-continuous data characterized by an excessive proportion of zeros and right-skewed continuous positive values appear frequently in medical research. One example would be the pharmaceutical expenditure (PE) data for which a substantial proportion of subjects investigated may report zero. Two-part mixed-effects models have been developed to analyse clustered measures of semi-continuous data from multilevel studies. In this study, we propose a new flexible two-part mixed-effects model with skew distributions for nested semi-continuous cost data under the framework of a Bayesian approach. The proposed model specification consists of two mixed-effects models linked by the correlated random effects: Part I) a model on the occurrence of positive values using a generalized logistic mixed model; and Part II) a model on the magnitude of positive values using a linear mixed model where the model errors follow skew distributions including beta-prime (BP). The proposed method is illustrated with pharmaceutical expenditure data from a multilevel observational study and the analytic results are reported by comparing potential models under different skew distributions. Simulation studies are conducted to assess the performance of the proposed model. The DIC3, LPML, WAIC, and LOO as the Bayesian model selection criteria and measures of divergence used to compare the models.
first_indexed 2024-04-12T11:24:37Z
format Article
id doaj.art-bc23ce29d2d3420faf4bba8f208647b9
institution Directory Open Access Journal
issn 1471-2288
language English
last_indexed 2024-04-12T11:24:37Z
publishDate 2022-11-01
publisher BMC
record_format Article
series BMC Medical Research Methodology
spelling doaj.art-bc23ce29d2d3420faf4bba8f208647b92022-12-22T03:35:15ZengBMCBMC Medical Research Methodology1471-22882022-11-0122111510.1186/s12874-022-01736-0Zero-augmented beta-prime model for multilevel semi-continuous data: a Bayesian inferenceNaser Kamyari0Ali Reza Soltanian1Hossein Mahjub2Abbas Moghimbeigi3Maryam Seyedtabib4Department of Biostatistics and Epidemiology, School of Health, Abadan University of Medical SciencesModeling of Noncommunicable Diseases Research Center, Hamadan University of Medical SciencesResearch Center for Health Sciences, School of Public Health, Hamadan University of Medical SciencesDepartment of Biostatistics and Epidemiology, School of Health, Research Center for Health, Safety and Environment, Alborz University of Medical SciencesDepartment of Biostatistics and Epidemiology, School of Health, Ahvaz Jundishapur University of Medical SciencesAbstract Semi-continuous data characterized by an excessive proportion of zeros and right-skewed continuous positive values appear frequently in medical research. One example would be the pharmaceutical expenditure (PE) data for which a substantial proportion of subjects investigated may report zero. Two-part mixed-effects models have been developed to analyse clustered measures of semi-continuous data from multilevel studies. In this study, we propose a new flexible two-part mixed-effects model with skew distributions for nested semi-continuous cost data under the framework of a Bayesian approach. The proposed model specification consists of two mixed-effects models linked by the correlated random effects: Part I) a model on the occurrence of positive values using a generalized logistic mixed model; and Part II) a model on the magnitude of positive values using a linear mixed model where the model errors follow skew distributions including beta-prime (BP). The proposed method is illustrated with pharmaceutical expenditure data from a multilevel observational study and the analytic results are reported by comparing potential models under different skew distributions. Simulation studies are conducted to assess the performance of the proposed model. The DIC3, LPML, WAIC, and LOO as the Bayesian model selection criteria and measures of divergence used to compare the models.https://doi.org/10.1186/s12874-022-01736-0Bayesian frameworkNon-negative dataTwo-part mixed-effects modelSkew distributionsPharmaceutical expenditure
spellingShingle Naser Kamyari
Ali Reza Soltanian
Hossein Mahjub
Abbas Moghimbeigi
Maryam Seyedtabib
Zero-augmented beta-prime model for multilevel semi-continuous data: a Bayesian inference
BMC Medical Research Methodology
Bayesian framework
Non-negative data
Two-part mixed-effects model
Skew distributions
Pharmaceutical expenditure
title Zero-augmented beta-prime model for multilevel semi-continuous data: a Bayesian inference
title_full Zero-augmented beta-prime model for multilevel semi-continuous data: a Bayesian inference
title_fullStr Zero-augmented beta-prime model for multilevel semi-continuous data: a Bayesian inference
title_full_unstemmed Zero-augmented beta-prime model for multilevel semi-continuous data: a Bayesian inference
title_short Zero-augmented beta-prime model for multilevel semi-continuous data: a Bayesian inference
title_sort zero augmented beta prime model for multilevel semi continuous data a bayesian inference
topic Bayesian framework
Non-negative data
Two-part mixed-effects model
Skew distributions
Pharmaceutical expenditure
url https://doi.org/10.1186/s12874-022-01736-0
work_keys_str_mv AT naserkamyari zeroaugmentedbetaprimemodelformultilevelsemicontinuousdataabayesianinference
AT alirezasoltanian zeroaugmentedbetaprimemodelformultilevelsemicontinuousdataabayesianinference
AT hosseinmahjub zeroaugmentedbetaprimemodelformultilevelsemicontinuousdataabayesianinference
AT abbasmoghimbeigi zeroaugmentedbetaprimemodelformultilevelsemicontinuousdataabayesianinference
AT maryamseyedtabib zeroaugmentedbetaprimemodelformultilevelsemicontinuousdataabayesianinference